Subacute toxicity of antimicrobial peptide S-thanatin in ICR mice

Peptides

Volumn 36, Issue 1, 2012, Pages 109-113

  Wu, Guoqiu ^a   Deng, Xuepeng ^b   Wu, Pengpeng ^b   Shen, Zilong ^b   Xu, Hanmei ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antimicrobial peptide; ICR mice; S thanatin; Security; Subacute toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; POLYPEPTIDE ANTIBIOTIC AGENT; S THANATIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEHAVIOR; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE COUNT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOCRIT; HEMATOLOGY; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; LD 50; LEUKOCYTE COUNT; LIVER; LUNG; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; THROMBOCYTE; THROMBOCYTOCRIT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BEHAVIOR, ANIMAL; FEMALE; HEART; KIDNEY; LIVER; MALE; MICE; MICE, INBRED ICR; MYOCARDIUM; SPLEEN;

MUS;

EID: 84862123845     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.04.005     Document Type: Article

References (26)

1. A. Cherkasov, K. Hilpert, H. Jenssen, C.D. Fjell, M. Waldbrook, and S.C. Mullaly Use of artificial Intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs ACS Chem Biol 4 2008 65 74
2. J. Davies Inactivation of antibiotics and the dissemination of resistance genes Science 264 1994 375 382
3. P. Fehlbaum, P. Bulet, S. Chernysh, J.P. Briand, J.P. Roussel, and L. Letellier Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides Proc Natl Acad Sci U S A 93 1996 1221 1225
4. Y.J. Gordon, E.G. Romanowski, and A.M. McDermott A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs Current Eye Res 30 2005 505 515
5. R.E. Hancock, and H.G. Sahl Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 24 2006 1551 1557
6. R.E. Hancock, and M.G. Scott The role of antimicrobial peptides in animal defenses Proc Natl Acad Sci U S A 97 2000 8856 8861
7. H. Jenssen, P. Hamill, and R.E. Hancock Peptide antimicrobial agents Clin Microbiol Rev 19 2006 491 511
8. K.K. Kumarasamy, M.A. Toleman, T.R. Walsh, J. Bagaria, F. Butt, and R. Balakrishnan Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 10 2010 597 602
9. M.K. Lee, L. Cha, S.H. Lee, and K.S. Hahm Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide J Biochem Mol Biol 35 2002 291 296
10. N. Mandard, P. Sodano, H. Labbe, J.M. Bonmatin, P. Bulet, and C. Hetru Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data Eur J Biochem 256 1998 404 410
11. A.K. Marr, W.J. Gooderham, and R.E.W. Hancock Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr Opin Pharmacol 6 2006 468 472
12. P. Nicolas, D. Vanhoye, and M. Amiche Molecular strategies in biological evolution of antimicrobial peptides Peptides 24 2003 1669 1680
13. P.C. Oyston, M.A. Fox, S.J. Richards, and G.C. Clark Novel peptide therapeutics for treatment of infections J Med Microbiol 58 2009 977 987
14. D.L. Paterson Clinical experience with recently approved antibiotics Curr Opin Pharmacol 6 2006 486 490
15. B. Spellberg, J.H. Powers, E.P. Brass, L.G. Miller, and J.E. Edwards Jr. Trends in antimicrobial drug development: implications for the future Clin Infect Dis 38 2004 1279 1286
16. J. Travis Reviving the antibiotic miracle Science 264 1994 360 362
17. T.R. Walsh, J. Weeks, D.M. Livermore, and M.A. Toleman Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study Lancet Infect Dis 11 2011 355 362
18. X. Wang, Y. Song, J. Li, H. Liu, X. Xu, and R. Lai A new family of antimicrobial peptides from skin secretions of Rana pleuraden Peptides 28 2007 2069 2074
19. G.D. Wright Resisting resistance: new chemical strategies for battling superbugs Chem Biol 7 2000 R127 R132
20. G. Wu, J. Ding, L. Li, H. Wang, R. Zhao, and Z. Shen Activity of the antimicrobial peptide and thanatin analog S-thanatin on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures Curr Microbiol 59 2009 147 153
21. G. Wu, X. Fan, L. Li, H. Wang, J. Ding, and W. Hongbin Interaction of antimicrobial peptide S-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli Int J Antimicrob Agents 35 2010 250 254
22. G. Wu, X. Li, X. Deng, X. Fan, S. Wang, and Z. Shen Protective effects of antimicrobial peptide S-thanatin against endotoxic shock in mice introduced by LPS Peptides 32 2011 353 357
23. G. Wu, X. Li, X. Fan, H. Wu, S. Wang, and Z. Shen The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria Peptides 32 2011 1139 1145
24. G. Wu, H. Wu, X. Fan, R. Zhao, X. Li, and S. Wang Selective toxicity of antimicrobial peptide S-thanatin on bacteria Peptides 31 2010 1669 1673
25. G. Wu, H. Wu, L. Li, X. Fan, J. Ding, and X. Li Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin Biochem Biophys Res Commun 395 2010 31 35
26. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395